Chitobiosyldiphosphodolichol beta-mannosyltransferase
Chitobiosyldiphosphodolichol beta-mannosyltransferase is an enzyme that plays a crucial role in the process of N-linked glycosylation in eukaryotic cells. This enzyme is responsible for the transfer of a mannose residue from GDP-mannose to chitobiosyldiphosphodolichol, forming a key intermediate in the synthesis of the lipid-linked oligosaccharide precursor.
Function[edit]
Chitobiosyldiphosphodolichol beta-mannosyltransferase is involved in the early steps of the N-linked glycosylation pathway. This pathway is essential for the proper folding and function of many glycoproteins. The enzyme catalyzes the addition of a mannose residue to the growing oligosaccharide chain attached to the lipid carrier dolichol. This step is critical for the subsequent elongation and processing of the oligosaccharide precursor.
Mechanism[edit]
The enzyme uses GDP-mannose as a donor substrate and transfers the mannose residue to the chitobiosyldiphosphodolichol acceptor. The reaction occurs in the endoplasmic reticulum membrane, where the lipid-linked oligosaccharide is assembled before being transferred to nascent polypeptides.
Biological Importance[edit]
The activity of chitobiosyldiphosphodolichol beta-mannosyltransferase is essential for the proper assembly of the N-linked glycan precursor. Defects in this enzyme can lead to disorders in glycosylation, which can result in a variety of congenital disorders of glycosylation (CDGs). These disorders often have severe clinical manifestations, including developmental delays, neurological issues, and other systemic problems.
Related Enzymes[edit]
Chitobiosyldiphosphodolichol beta-mannosyltransferase is part of a larger family of glycosyltransferases that are involved in the synthesis of complex carbohydrates. Other related enzymes include:
See Also[edit]
- N-linked glycosylation
- Glycosyltransferase
- Dolichol
- Endoplasmic reticulum
- Congenital disorders of glycosylation
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
